Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GlaxoSmithKline sues Abbott over Norvir

Executive Summary

Four years after Abbott raised the price of Norvir by 400 percent, GSK files an antitrust complaint alleging Abbott sought to monopolize the market for protease inhibitor boosters and violated a business agreement in which GSK paid Abbott to co-promote its Lexiva for use with Norvir. GSK says it did not sue at the time of the price hike because it was reluctant to take a business partner to court and HIV patients had filed suit. The Nov. 9 complaint cites internal Abbott documents showing the company had considered other options to increase market share of its Kaletra, which incorporates Norvir, and that raising the price of Norvir might lead to federal investigations. Pharmacy chains filed a similar suit Oct. 26...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS049022

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel